by Melinda Misuraca on Aug 21, 2012
CBD pot delivers the health benefits without the high. Illustration by David Bonn.
Medical marijuana has gotten a bad rap in Northern California, and perhaps for good reason. Dispensary logos typically feature a red cross backlit by a neon pot leaf, with maybe the image of a wheelchair and the word “compassion” squeezed in somewhere; meanwhile, a “nudge-nudge, wink-wink” atmosphere pervades many a dispensary waiting area, filled as they are with a high number of male “patients” between the ages of 18 and 40 who are there to be treated for “back pain” and “insomnia,” their prescriptions written by doctors who advertise in the classifieds and on billboards. It’s not surprising that the boundary between recreational and medicinal cannabis can sometimes seem as hazy as the interior of a reggae dance hall.
But new research in medical marijuana is shocking scientists in the industry right out of their white lab coats, and its implications for treating medical conditions that range from cancer to schizophrenia are poised to take federal regulatory bulwarks by storm.
If THC is marijuana’s quintessential party girl, a lesser-known molecule called cannabidiol (CBD) is her quieter littler sister, a new wave wonder child with a good-girl twist. Not only has CBD shown seemingly supernatural effects on a variety of ailments, it is nonpsychoactive, moderating the euphoric, “stony” effects of THC and allowing patients to use their medicine without ending up on the couch all day watching whole seasons of Weeds.
Cannabis Through the Ages
To better understand the CBD revelation, let us first take a stroll down Mary Jane Lane with the help of a new book. Smoke Signals, a vast compendium on cannabis by Northern California resident Martin Lee, is just out from Scribner. Diminutive with a shock of mad-scientist hair and a perpetual look of bemusement, Lee is an investigative journalist and one of the founders of the organization FAIR (Fairness and Accuracy in Reporting). Equal parts social history, compelling research and political commentary, Smoke Signalsis populated with the artists, writers and thinkers for whom cannabis lit a green fuse of inspiration—from Balzac to Baudelaire, the Beatles to Bob Dylan—as well as the scientists and activists who have doggedly fought to liberate the perennially misunderstood plant.
The pot narrative begins 6,000 years ago. First cultivated in the Hindu Kush, it was brought by invading Aryan tribes to India, where it was associated with the Hindu god Shiva and was smoked, ingested and made into fuel, cloth and rope. After observing its usefulness in the East, W. B. O’Shaughnessy introduced cannabis to the West in the 1800s, where it was listed in The United States Pharmacopeia and the National Formulary until the 1930s. Prescribed for over 100 ailments, marijuana was ingested by our grandparents in the cough remedies, nervines and analgesics common in the day and bought from such upstanding establishments as Sears, Roebuck and Company.
Lee’s book describes how, during the Great Depression, the newly created Federal Bureau of Narcotics found itself without budget or scapegoat, inspiring the agency’s director, Harry Anslinger, to fashion himself into a righteous anti-pot crusader. Anslinger gave his government-sanctioned agenda a blatantly racist top-spin. “Reefer,” he said, “makes darkies think they are as good as white men,” causes “white women to seek sexual relations with Negroes” and inspires the creation of “Satanic music of Jazz and Swing.” The bureau also linked the drug with insanity and claimed a direct correlation between marijuana and violence, and even death.